for our Bi-Monthly Breakfast Forum
with The Cancer Prevention & Research Institute of Texas (CPRIT)
Where:
UNT Health Science Center
Medical Education and Training Building (MET)
1000 Montgomery Street and Bunting Ave. Room MET-125S
Fort Worth, TX 76107
8-8:30 Networking
8:30-9:20 Feature Presentations
9:20-9:30 Closing Comments
9:30-10 Networking
Driving Directions
Contact:
Miriam D'Souza
bionorthTX
630-770-0362
miriam@bionorthtx.org
bionorthTX..."Changing lives through the convergence of science and industry"
bionorthTX is an independent, non-profit 501(c) (6) trade association serving and representing the life sciences industry in the northern region of Texas. Our members include companies, organizations, and individuals engaged in, or supportive of, research, development and commercialization of life science technologies. bionorthTX was formed in February, 2014 by industry individuals who believed that the region needed representation by companies and individuals whose focus has been, and will continue to be, centered on the life sciences. The Association’s mission is to help to foster an environment in North Texas that supports life science research, innovation and commercialization. We endeavor to increase the competitiveness of North Texas as a premier global location for biotechnology/biomedical research, education and industry. By encouraging the development of a rich ecosystem, we endeavor to strengthen the economy of our local communities, making North Texas a sought out place to live and work.
On December 8th, you will meet Mike Lang who will speak about how CPRIT has changed the face of reserch and innovation in Texas and how your company can benefit from partnring with CPRIT for funding to take your company to the next level. Mike will also share his experience on what constitutes the best "pitch" presentation to gain the attention of potential investors.
Texas voters overwhelmingly approved a constitutional amendment in 2007 establishing the Cancer Prevention and Research Institute of Texas (CPRIT) and authorizing the state to issue $3 billion in bonds to fund groundbreaking cancer research and prevention programs and services in Texas. CPRIT’s goal is to expedite innovation in cancer research and product development, and to enhance access to evidence-based prevention programs throughout the state. Under the guidance of its governing body, the Oversight Committee, CPRIT accepts applications and awards grants for a wide variety of cancer-related research and for the delivery of cancer prevention programs and services by public and private entities located in Texas. All CPRIT-funded research will be conducted in state by Texas-based scientists and reflect CPRIT’s mission to attract and expand the state’s research capabilities and create high quality new jobs in Texas.
Mike Lang, Chief Product Development Research Officer
Mr. Lang leads CPRIT’s product development research program, designed to accelerate the progression of new cancer drugs, diagnostics, and therapies from the laboratory into clinical practice. His multi-state experience includes founding and serving as chief executive officer of a cancer diagnostic company, serial entrepreneurship, and managing a portfolio for an early stage investment.
Prior to joining CPRIT in November 2015, Mr. Lang was the founder and CEO of NanoVision, a cancer diagnostics company. He headed business development at the venture capital-funded wound healing company Gilatech, where he led its novel biomaterial therapy. Mr. Lang oversaw a company restructuring as president of Dallas-based Galt Medical, served as a product manager at Johnson & Johnson, and was vice president of business development at BioEnterprise, where he directed the startup and growth of early stage firms.
Mr. Lang has a bachelor’s in biomedical engineering from Northern Arizona University and a master’s in business administration from Arizona State University.
THANK YOU TO OUR ANNUAL BREAKFAST FORUM SPONSOR SGI
AND TO OUR HOST UNTHSC!
